Photoelectrochemical biosensor of HIV-1 based on cascaded photoactive materials and triple-helix molecular switch

Abstract In this work, an ultrasensitive photoelectrochemical (PEC) biosensor was proposed to detect nucleic acids on the basis of cascaded photoactive materials and triple-helix molecular switch. DNA sequence of human immunodeficiency virus type 1 (HIV-1) was chosen as the target DNA (T-DNA). Cascaded photoactive structure was formed via different sizes of CdTe quantum dots (QDs) sensitized ZnO nanorods (ZnO NRs), which was employed as a cascaded photoactive interface to amplify the photocurrent signal. A hairpin structure DNA (H-DNA) as capture probe was conjugated onto the photoactive interface through amide bond, and then a single-stranded DNA modified with gold nanoparticles labeled alkaline phosphatase (ALP-Au NPs-DNA) at each end was introduced to hybridize with the H-DNA to form a triple-helix conformation. The T-DNA detection was based on the photocurrent response change resulted from conformation change of the triple-helix molecule after hybridization with T-DNA. In the absence of T-DNA, the triple-helix molecule was in a closed state and the ALP of ALP-Au NPs-DNA could specifically catalyze the ascorbic acid 2-phosphate (AAP) to generate ascorbic acid (AA) as electron donors, which resulted in a significant photocurrent response due to the rapid electron transfer process. However, in the presence of T-DNA, the T-DNA hybridized with the ALP-Au NPs-DNA molecule, which caused triple-helix molecule in an opened state and compelled ALP-Au NPs-DNA away from the electrode surface, resulting in the absence of ALP which could catalyze AAP to generate AA. Subsequently, the photocurrent response significantly decreased. The proposed PEC biosensor not only had a wide detection range of 1fM-1nM and low detection limit (0.65 fM), but also showed excellent reproducibility, specificity and stability, which had great application prospect and opened up a new research method in the early clinical diagnosis and cancer research.